Key terms
About CVAC
CureVac BV is a clinical-stage biopharmaceutical company, which engages in developing transformative medicines based on messenger ribonucleic acid (mRNA). Its product portfolio includes clinical and preclinical candidates across multiple disease indications in prophylactic vaccines, oncology, and protein therapy. The company was founded by Ingmar Hoerr and Florian von der Mülbe in 2000 and is headquartered in Tübingen, Germany.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest CVAC news
Jan 05
10:00am ET
Analysts Offer Insights on Healthcare Companies: Fusion Pharmaceuticals (FUSN), CureVac (CVAC) and Immunocore Holdings (IMCR)
Jan 05
7:53am ET
CureVac announces Phase 2 interim data from COVID-19 vaccine program
Dec 25
1:00am ET
Analysts Offer Insights on Healthcare Companies: CureVac (CVAC) and Evolus (EOLS)
Dec 20
8:21am ET
Analysts’ Opinions Are Mixed on These Healthcare Stocks: CureVac (CVAC), Marinus (MRNS) and Vertex Pharmaceuticals (VRTX)
Dec 19
8:31pm ET
CureVac price target lowered to $6.40 from $8 at BofA
Dec 19
8:31pm ET
Analysts Offer Insights on Healthcare Companies: Ascendis Pharma (ASND), CureVac (CVAC) and BioNTech SE (BNTX)
Dec 19
1:45pm ET
CureVac Buy Rating Affirmed Despite Patent Setback, Strong Appeal Prospects Anticipated
Dec 19
9:42am ET
CureVac announces German Federal Patent Court decision in BioNTech litigation
Dec 19
9:27am ET
CureVac to appeal patent decision before German Federal Court of Justice
Dec 19
9:01am ET
Germany’s patent court invalidates CureVac patent, Reuters reports
Nov 16
7:20am ET
Wall Street Analysts Are Bullish on Top Healthcare Picks
Nov 14
12:50pm ET
Analysts Offer Insights on Healthcare Companies: CureVac (CVAC), MoonLake Immunotherapeutics (MLTX) and Cara Therapeutics (CARA)
No recent news articles are available for CVAC
No recent press releases are available for CVAC
CVAC Financials
Key terms
Ad Feedback
CVAC Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
CVAC Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range